8:00am – 8:55am

Breakfast

8:55am – 9:00am

Argyle Executive Forum Opening Remarks

9:00am – 9:10am

Chief Content Officer Opening Remarks

Michael E.S. Frankel
Senior Vice President, Business Development and M&A
LexisNexis Group

9:10am – 9:15am

Introducing Mark Copman

Nilüfer Durak
Managing Director 
Aon Mergers & Acquisitions Group

9:15am – 9:45am

“Corporate Development Lessons Learned”

Session topics include but are not limited to:

• A look back at 2009- what we've learned and what we can take into 2010
• "Offense v. Defense" - how the role of the corporate development professional changes from periods of recession to periods of economic growth
• How has and how will 3M use corporate development to grow its organization?

Mark Copman
Vice President, Corporate Development
3M

9:50am – 10:30am

Panel Discussion

“Cross Border Deals and Emerging Markets”

Session topics include but are not limited to:

• Unique characteristics of cross border deals- due diligence requirements and the management of risk, reputation and timeliness
• How attractive are emerging markets? Is now a good time to look abroad to capture market growth?
• New sources of geographic competition
• What can we take from our cumulative experiences as they relate to emerging market growth? 

Moderator:
Matthew Philips
Senior Reporter
Newsweek Magazine

Panelists:
Stephen M. Besen
Partner
Shearman & Sterling LLP

Mark Mlotek
EVP Corporate Business Development
Henry Schein, Inc.

Miguel Romero
Corporate Development Manager, Mergers & Acquisitions
Sempra Energy

Raul A. Trillo, Jr., MD, MBA
VP Global Strategy
Baxter Healthcare Corporation

10:30am – 11:00am

Coffee Break

11:00am – 11:30am

“A Discussion: Corporate Development Defined”

Naren B. Srinivasan
Vice President, Corporate Development & Strategy
Mead Westvaco

Interviewed by:

Michael E.S. Frankel
Senior Vice President, Business Development and M&A
LexisNexis Group

11:35am – 12:15pm

Panel Discussion presented by PricewaterhouseCoopers

“The Role of Divestitures in Today’s Environment”

Session topics include but are not limited to:

• Analyzing the strategic and financial objectives of your portfolio- when and what to divest
• Deciding to divest – the internal decision-making process
• Considerations on purchasing a business in a divestitures process- the buyer’s and seller’s perspective
• Asset valuations- finding the common ground 

Moderator:
Mark D. Ross
Partner
PricewaterhouseCoopers

Panelists:
David Blumberg
Head of Strategic Development 
Iconix

Michael Oster
Senior Vice President Mergers & Acquisitions
Alon USA

Ahmad Shamim
Partner, Transaction Services 
PricewaterhouseCoopers

Todd Tauber
Director, Corporate Development
The Economist Group

12:20pm – 12:50pm

“A Pharmaceutical Perspective: Growth, Development and M&A”

Session topics include but are not limited to:

• How the pharmaceutical industry has and continues to use M&A to grow
• The Pfizer/Wyeth merger- the strategy behind the deal

Kristin Peck
Senior Vice President, Worldwide Strategy and Innovation
Pfizer Inc

12:50pm – 2:00pm

Lunch 

2:00pm – 2:05pm

Introducing "The Current M&A Boom" Panel Discussion

Matt Porzio
Vice President, Product Marketing, Mergers & Acquisitions 
Intralinks

2:05pm – 2:45pm

Panel Discussion

“The Current M&A Boom"

Session topics include but are not limited to:

• As the recession subsides, an uptick in M&A is expected to follow. What will this potential boom look like? Deal terms? Volume of transactions? Risks v. returns?
• Is an M&A boom a good thing or a bad thing- the pros and cons of an accelerated M&A environment
• The role of M&A in your organization- past, present and future
• What are the ways your organization measures ROI of M&A activity to help further enforce the business decision post deal? 

Moderator:
Anton Sahazizian 
Managing Director 
UBS Investment Bank- Mergers & Acquisitions

Panelists:
Tom Angell
Principal
Rothstein Kass

Dr. Andreas Guldin
Vice Chairman and Chief Strategy Officer
The Great Atlantic & Pacific Tea Co., Inc.

Mark L. Keim
Head of Corporate Development 
Aetna

Karl Kleiderer
Vice President, Acquisitions & Divestitures
Goodrich Corporation

2:50pm – 3:20pm

“Transformation for our Times: How Dow is Using Strategy and Portfolio Optimization to Transform the Company”

Session topics include but are not limited to:

• How the board of directors and senior management craft strategy- financial plan, megatrends and participation strategy
• Portfolio management techniques- asset light joint ventures and the acquisition of Rohm and Haas
• How management communicates strategy to employees and operationalizes it to ensure complete alignment
• A look into the future of Dow's strategy and some rules for successful strategy development and execution

George Biltz
Corporate Vice President, Strategic Development & Planning
The Dow Chemical Company

*This session is off the record

3:25pm – 3:55pm

“A Consolidation Strategy that Works”

Jim Cohen
Executive Vice President- Mergers & Acquisitions
Consolidated Graphics, Inc.

3:55pm – 4:05pm

Chief Content Officer Closing Remarks

Michael E.S. Frankel
Senior Vice President, Business Development and M&A
LexisNexis Group

4:05pm – 4:10pm

Argyle Executive Forum Closing Remarks

4:10pm – 5:10pm

Closing Reception

*Please note agenda is subject to change